Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy (Nature Communications, (2019), 10, 1, (657), 10.1038/s41467-019-08593-4)

Jennifer L. Caswell-Jin, Katherine McNamara, Johannes G. Reiter, Ruping Sun, Zheng Hu, Zhicheng Ma, Jie Ding, Carlos J. Suarez, Susanne Tilk, Akshara Raghavendra, Victoria Forte, Suet Feung Chin, Helen Bardwell, Elena Provenzano, Carlos Caldas, Julie Lang, Robert West, Debu Tripathy, Michael F. Press, Christina Curtis

Research output: Contribution to journalComment/debate

Abstract

The original version of this Article omitted from the Author Contributions statement that ‘R.S. and J.G.R contributed equally to this work.’ This has been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish (US)
Article number2433
JournalNature communications
Volume10
Issue number1
DOIs
StatePublished - Dec 1 2019
Externally publishedYes

PubMed: MeSH publication types

  • Published Erratum

Fingerprint Dive into the research topics of 'Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy (Nature Communications, (2019), 10, 1, (657), 10.1038/s41467-019-08593-4)'. Together they form a unique fingerprint.

  • Cite this

    Caswell-Jin, J. L., McNamara, K., Reiter, J. G., Sun, R., Hu, Z., Ma, Z., Ding, J., Suarez, C. J., Tilk, S., Raghavendra, A., Forte, V., Chin, S. F., Bardwell, H., Provenzano, E., Caldas, C., Lang, J., West, R., Tripathy, D., Press, M. F., & Curtis, C. (2019). Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy (Nature Communications, (2019), 10, 1, (657), 10.1038/s41467-019-08593-4). Nature communications, 10(1), [2433]. https://doi.org/10.1038/s41467-019-10456-x